Literature DB >> 33965767

Perturbation of serum metabolome in relation to type 2 diabetes mellitus and urinary levels of phthalate metabolites and bisphenols.

Yishuang Duan1, Hongwen Sun2, Yiming Yao3, Liping Han4, Liming Chen5.   

Abstract

BACKGROUND: Emerging evidence has proved the associations between exposure to phthalates (PAEs) and bisphenols and type 2 diabetes mellitus (T2DM), but the underlying mechanisms for these associations are poorly understood. Metabolomics is a powerful tool to identify differential metabolites and metabolic pathways related to diseases and chemical exposure, which may reveal underlying mechanisms. However, little is known about the roles of metabolism in the associations for PAE and bisphenol exposure with T2DM.
OBJECTIVES: The purpose of the study was to investigate the roles of metabolism in the associations for exposure to PAEs and bisphenols with T2DM.
METHODS: In this study, 60 T2DM cases and 60 controls, who were matched in age, sex, and body mass index (BMI), were selected from the total study population in our previous studies. Fasting blood and spot urine samples of the volunteers were used for non-targeted metabolomics analysis and determination of phthalate metabolites (mPAEs) and bisphenols, respectively. The associations of urinary mPAEs and bisphenols with screened metabolic biomarkers in metabolomics analysis were analyzed using multiple linear regression models.
RESULTS: Based on non-targeted metabolomics, 19 serum metabolic biomarkers were screened between T2DM cases and controls, mostly related to galactose metabolism, amino acid metabolism, and pyrimidine metabolism. More than half of mPAEs were mostly positively associated with up-regulated metabolic biomarkers and negatively associated with down-regulated biomarkers. Different from PAEs, no evident results suggested the roles of metabolism in the associations between bisphenol exposure and T2DM.
CONCLUSIONS: Combined with the positive associations between most urinary mPAEs and T2DM in our previous study, our findings indicated that PAE exposure may contribute to T2DM risk through disturbing galactose metabolism, amino acid metabolism (especially arginine biosynthesis and alanine, aspartate and glutamate metabolism), and pyrimidine metabolism.
Copyright © 2021 The Author(s). Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Arginine biosynthesis; Metabolomics; Phthalates; Pyrimidine metabolism; Type 2 diabetes mellitus

Year:  2021        PMID: 33965767     DOI: 10.1016/j.envint.2021.106609

Source DB:  PubMed          Journal:  Environ Int        ISSN: 0160-4120            Impact factor:   9.621


  4 in total

1.  Targeted metabolomics analysis of amino acids and acylcarnitines as risk markers for diabetes by LC-MS/MS technique.

Authors:  Shaghayegh Hosseinkhani; Babak Arjmand; Arezou Dilmaghani-Marand; Sahar Mohammadi Fateh; Hojat Dehghanbanadaki; Niloufar Najjar; Sepideh Alavi-Moghadam; Robabeh Ghodssi-Ghassemabadi; Ensieh Nasli-Esfahani; Farshad Farzadfar; Bagher Larijani; Farideh Razi
Journal:  Sci Rep       Date:  2022-05-19       Impact factor: 4.996

2.  Modulation of Insulin Resistance, Dyslipidemia and Serum Metabolome in iNOS Knockout Mice following Treatment with Nitrite, Metformin, Pioglitazone, and a Combination of Ampicillin and Neomycin.

Authors:  Hobby Aggarwal; Priya Pathak; Yashwant Kumar; Kumaravelu Jagavelu; Madhu Dikshit
Journal:  Int J Mol Sci       Date:  2021-12-24       Impact factor: 5.923

3.  Release of Heavy Metals from Plastic Statuettes Used as Souvenirs and/or Toys Handled by Children.

Authors:  Pietro Pandolfi; Maria Pia Sammartino; Giovanni Visco; Pasquale Avino; Virgilio Stillittano
Journal:  Int J Environ Res Public Health       Date:  2021-12-26       Impact factor: 3.390

4.  BushenHuoxue Recipe for the Treatment of Prethrombotic State of ACA-Positive Recurrent Miscarriage via the Regulation of the PI3K-AKT Signaling Pathway.

Authors:  Xuan Yang; Shulan Su; Qingling Ren; Lijing Liu; Jiashang Li; Wen Zhang; Ke Cai; Zhuo Xu; Xin Pan
Journal:  Evid Based Complement Alternat Med       Date:  2022-02-14       Impact factor: 2.629

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.